Stock Report

All about this stock under one free report Last Updated: 27-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

ChemoCentryx (CCXI) Key Ratios

Stock Card factsheet share-fund-plan-icon

$14.82

up-down-arrow $0.37 (2.56%)

As on 26-Aug-2026 16:28EDT

Market cap

info icon

$812 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT -- -- -- -- --
Net Profit -166,149.07 -610,835.56 -- -- 14.95
EPS -166,169.16 -531,321.32 -- -- -8.23
Book Value -- -- -- -- 4.20
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info ----------
Net Margin info ----------
Return on equity info -----40.17----
Return on Capital info ----------
Return on Assets info -----63.24----
Debt to Equity (x) info ----0.00----

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
-34.71
-20.62
-41.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-40.17

Lower than Peers by 75.21

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
-40.17
--
-39.23
-24.51
-137.45
Peer Median
35.04
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-63.24

Lower than Peers by 61.37

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
-63.24
--
-27.90
-15.21
-28.28
Peer Median
-1.88
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
-417.24
-81.23
-148.36
Peer Median
3.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
-398.26
-82.19
-135.62
Peer Median
-4.02
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
-0.50
0.80
-0.16
Peer Median
17.53
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
-155.06
1.18
-45.17
Peer Median
35.10
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

--

--

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
-138.01
0.24
-46.15
Peer Median
23.15
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

--

--

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
-1.24
0.14
-0.28
Peer Median
40.24
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

7,895,814.75

Higher than Peers by 7,895,793.42

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
7,895,814.75
--
--
--
--
Peer Median
21.33
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
0.08
0.17
0.32
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
0.07
0.02
0.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.01

Lower than Peers by 1.13

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
0.01
8.13
4.27
8.56
2.95
Peer Median
1.15
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.01

Lower than Peers by 1.12

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
0.01
--
4.26
--
--
Peer Median
1.13
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
-49.89
-19.94
-24.82
Peer Median
9.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
1.28
0.26
0.49
Peer Median
27.63
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
0.07
0.18
0.18
Peer Median
0.21
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
3.29
0.97
11.35
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
1,029.23
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
11,865.18
--
6.49
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
-10,832.66
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
-19.34
-73.83
-40.63
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
8.91
10.60
34.16
Peer Median
1.27
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

--

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
--
--
-17.58
-71.54
-40.68
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

812

Higher than Peers by 239

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-21
Dec-20
Dec-19
ChemoCentryx (CCXI)
812
--
--
--
--
Peer Median
572
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...